antimicrobial resistance (AMR)

How to fix the vicious cycle of antibiotics market decay

In this series of blogs, we illuminate the mechanisms driving the collapse of the antibiotics industry, discuss a case study, and propose ways to bring stakeholders together to come to a solution. At ttopstart, we believe such healthcare challenges can be evaded by creative strategic thinking and pragmatism.

“At ttopstart, we have an integral interest in removing the roadblocks holding back the introduction of novel antibiotic compounds. We are of the opinion that public awareness on the matter is the first hurdle to take.”

–  Jelle Eikelhof msc, Consultant

Why the antibiotics market needs to be fixed

Why the antibiotics market needs to be fixed

Why the antibiotics market needs to be fixedWe are still in the middle of the COVID-19 crisis, but another potentially larger crisis is ahead that threatens our global healthcare system; the anti-microbial resistance (AMR) crisis. Whilst we weren’t ready for COVID-19,...

Read more

Download brochure

Our ‘Impactful Funding’ brochure contains relevant insights on how to build your funding strategy and acquire funds. Find out how you can turn your innovations into real impact.